JanOne
JanOne is a Las Vegas-based company focused on developing non-addictive pain-relieving drugs, with its lead candidate, JAN101, targeting Peripheral Arterial Disease. The company also operates Appliance Recycling Centers of America, Inc. and trades under the symbol JAN on the NASDAQ.
History
JanOne is a company that trades under the symbol JAN on the NASDAQ. The company is headquartered in Las Vegas, Nevada, and aims to develop treatments for diseases that cause severe pain. Originally, JanOne operated under the brand name Appliance Recycling Centers of America, Inc (ARCA). As a part of its evolution, JanOne has acquired ALT 5 Sigma Inc., a prominent blockchain financial technology provider.
Pharmaceutical Focus
JanOne is focused on developing non-addictive pain-relieving drugs. The company aims to address severe pain through innovative treatments that do not rely on addictive substances. The lead drug candidate, JAN101, is designed to treat Peripheral Arterial Disease (PAD). Phase 2b clinical trials for JAN101 are expected to begin in early 2021, marking a significant milestone in the drug's development journey.
Products
JanOne's leading product is JAN101, a drug candidate aimed at treating Peripheral Arterial Disease (PAD). This treatment is part of JanOne's broader focus on creating non-addictive pain relief solutions for diseases that cause severe pain. JAN101 is set to enter Phase 2b clinical trials, highlighting its advanced stage in the drug development pipeline.
Acquisition of ALT 5 Sigma Inc.
JanOne has acquired ALT 5 Sigma Inc., a company recognized for its next-generation blockchain financial technology. This acquisition indicates JanOne's strategic expansion into the fintech sector, complementing its core focus on pharmaceutical advancements. ALT 5 Sigma Inc. brings expertise in blockchain technology, enhancing JanOne's technological capabilities.
Headquarters
JanOne is headquartered in Las Vegas, Nevada. This location serves as the central hub for the company's pharmaceutical research and business operations. The Nevada-based headquarters supports JanOne's efforts in developing and bringing non-addictive pain-relieving drugs to the market.